Cercar

01/11/2021 Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
Arab, JP, Diaz, LA, Baeza, N, Idalsoaga, F, Fuentes-Lopez, E, Arnold, J, Ramirez, CA, Morales-Arraez, D, Ventura-Cots, M, Alvarado-Tapias, E, Zhang, W, Clark, V, Simonetto, D, Ahn, JC, Buryska, S, Mehta, TI, Stefanescu, H, Horhat, A, Bumbu, A, Dunn, W, Attar, B, Agrawal, R, Haque, ZS, Majeed, M, Cabezas, J, Garcia-Carrera, I, Parker, R, Cuyas, B, Poca, M, Soriano, G, Sarin, SK, Maiwall, R, Jalal, PK, Abdulsada, S, Higuera-de la Tijera, MF, Kulkarni, AV, Rao, PN, Salazar, PG, Skladany, L, Bystrianska, N, Prado, V, Clemente-Sanchez, A, Rincon, D, Haider, T, Chacko, KR, Cairo, F, Coelho, MD, Romero, GA, Pollarsky, FD, Restrepo, JC, Castro-Sanchez, S, Toro, LG, Yaquich, P, Mendizabal, M, Garrido, ML, Narvaez, A, Bessone, F, Marcelo, JS, Piombino, D, Dirchwolf, M, Arancibia, JP, Altamirano, J, Kim, W, Araujo, RC, Rojo, AD, Vargas, V, Rautou, PE, Issoufaly, T, Zamarripa, F, Torre, A, Lucey, MR, Mathurin, P, Louvet, A, Garcia-Tsao, G, Gonzalez, JA, Verna, E, Brown, RS, Roblero, JP, Abraldes, JG, Arrese, M, Shah, VH, Kamath, PS, Singal, AK, Bataller, R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. JOURNAL OF HEPATOLOGY. 2021; 75(5)DOI:10.1016/j.jhep.2021.06.019. PMID:34166722. IF:30.083(Q1/1D).
01/10/2021 Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?"
Alvarado-Tapias, E, Vilades, D, Brujats, A, Villanueva, C. Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?". JOURNAL OF HEPATOLOGY. 2021; 75(4)DOI:10.1016/j.jhep.2021.06.026. PMID:34224780. IF:30.083(Q1/1D).
01/09/2021 Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
Villanueva, C, Albillos, A, Genesca, J, Garcia-Pagan, JC, Brujats, A, Calleja, JL, Aracil, C, Banares, R, Morillas, RM, Poca, M, Penas, B, Augustin, S, Abraldes, JG, Alvarado, E, Torres, F, Bosch, J. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. JOURNAL OF HEPATOLOGY. 2021; 75(3)DOI:10.1016/j.jhep.2021.04.022. PMID:33905794. IF:30.083(Q1/1D).
01/09/2021 Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Ampuero, J, Aller, R, Gallego-Duran, R, Crespo, J, Abad, J, Gonzalez-Rodriguez, A, Gomez-Camarero, J, Caballeria, J, Lo Iacono, O, Ibanez, L, Garcia-Samaniego, J, Martin-Mateos, R, Frances, R, Fernandez-Rodriguez, C, Diago, M, Soriano, G, Andrade, RJ, Latorre, R, Jorquera, F, Morillas, RM, Escudero, D, Estevez, P, Hernandez-Guerra, M, Augustin, S, Pareja-Megia, MJ, Banales, JM, Aspichueta, P, Benlloch, S, Rosales, JM, Salmeron, J, Turnes, J, Romero-Gomez, M. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. LIVER INTERNATIONAL. 2021; 41(9)DOI:10.1111/liv.14898. PMID:33896100. IF:8.754(Q1/2D).